Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma

被引：0
|
作者：
Ryszard Swoboda
Sebastian Giebel
Wanda Knopińska-Posłuszny
Ewa Chmielowska
Joanna Drozd-Sokołowska
Ewa Paszkiewicz-Kozik
Waldemar Kulikowski
Michał Taszner
Włodzimierz Mendrek
Jacek Najda
Tomasz Czerw
Magdalena Olszewska-Szopa
Anna Czyż
Agnieszka Giza
Wojciech Spychałowicz
Edyta Subocz
Paweł Szwedyk
Aleksandra Krzywon
Agata Wilk
Jan Maciej Zaucha
机构：
[1] Maria Sklodowska-Curie National Research Institute of Oncology,Department of Bone Marrow Transplantation and Oncohematology
[2] Gliwice branch,Department of Hematology and Bone Marrow Transplantation
[3] Pomeranian Hospitals,Department of Oncology
[4] Oncologic Hospital,Department of Hematology, Oncology and Internal Diseases
[5] Oncology Centre,Department of Lymphoid Malignancies
[6] Medical University of Warsaw,Department of Hematology
[7] Maria Sklodowska-Curie National Research Institute of Oncology,Department of Hematology and Transplantology
[8] Warsaw branch,Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation
[9] Independent Public Health Care Ministry of the Interior of Warmia and Mazury Oncology Center,Department of Hematology
[10] Medical University of Gdańsk,InternalMedicine and Oncology Clinic
[11] Wrocław Medical University,Department of Hematology
[12] Jagiellonian University,Department of Hematology
[13] Silesian Medical University,Department of Biostatistics and Bioinformatics
[14] Military Institute of Medicine,undefined
[15] Ludwik Rydygier Hospital,undefined
[16] Maria Sklodowska-Curie National Research Institute of Oncology,undefined
[17] Gliwice Branch,undefined
来源：
Annals of Hematology | 2021年 / 100卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A Correction to this paper has been published: https://doi.org/10.1007/s00277-021-04503-1
引用
收藏
页码：1919 / 1919
相关论文
共 50 条
  • [1] High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin Lymphoma
    Ryszard Swoboda
    Sebastian Giebel
    Wanda Knopińska-Posłuszny
    Ewa Chmielowska
    Joanna Drozd-Sokołowska
    Ewa Paszkiewicz-Kozik
    Waldemar Kulikowski
    Michał Taszner
    Włodzimierz Mendrek
    Jacek Najda
    Tomasz Czerw
    Magdalena Olszewska-Szopa
    Anna Czyż
    Agnieszka Giza
    Wojciech Spychałowicz
    Edyta Subocz
    Paweł Szwedyk
    Aleksandra Krzywon
    Agata Wilk
    Jan Maciej Zaucha
    [J]. Annals of Hematology, 2021, 100 : 1755 - 1767
  • [2] High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma (February, 10.1007/s00277-021-04448-5, 2021)
    Swoboda, Ryszard
    Giebel, Sebastian
    Knopinska-Posluszny, Wanda
    Chmielowska, Ewa
    Drozd-Sokolowska, Joanna
    Paszkiewicz-Kozik, Ewa
    Kulikowski, Waldemar
    Taszner, Michal
    Mendrek, Wlodzimierz
    Najda, Jacek
    Czerw, Tomasz
    Olszewska-Szopa, Magdalena
    Czyz, Anna
    Giza, Agnieszka
    Spychalowicz, Wojciech
    Subocz, Edyta
    Szwedyk, Pawel
    Krzywon, Aleksandra
    Wilk, Agata
    Zaucha, Jan Maciej
    [J]. ANNALS OF HEMATOLOGY, 2021, 100 (07) : 1919 - 1919
  • [3] A Phase I Study of Gemcitabine and Bendamustine in Relapsed/Refractory Hodgkin Lymphoma
    Cohen, Jonathon B.
    Wei, Lai
    Maddocks, Kami J.
    Heffner, Leonard T.
    Langston, Amelia
    Flowers, Christopher
    Devine, Steven M.
    Blum, Kristie A.
    [J]. BLOOD, 2015, 126 (23)
  • [4] A phase I study of gemcitabine and bendamustine in relapsed/refractory Hodgkin's lymphoma
    Cohen, Jonathon Brett
    Wei, Lai
    Maddocks, Kami J.
    Heffner, Leonard T.
    Langston, Amelia A.
    Flowers, Christopher
    Devine, Steven M.
    Blum, Kristie A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin
    Zinzani, Pier Luigi
    Derenzini, Enrico
    Pellegrini, Cinzia
    Celli, Monica
    Broccoli, Alessandro
    Argnani, Lisa
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (05) : 681 - 683
  • [6] The efficacy and safety of gemcitabine, dexamethasone, and cisplatine (GDP) therapy for relapsed/refractory lymphoma
    Nozawa, Kazuki
    Sugiyama, Keiji
    Hasegawa, Yuta
    Nakamura, Hiroyuki
    Hirano, Daiki
    Tokunaga, Takashi
    Miyata, Yasuhiko
    Kunitomi, Akane
    Ida, Hiroatsu
    Nagai, Hirokazu
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 147 - 148
  • [7] Phase II Study of Bendamustine in Relapsed and Refractory Hodgkin Lymphoma
    Moskowitz, Alison J.
    Hamlin, Paul A., Jr.
    Perales, Miguel-Angel
    Gerecitano, John
    Horwitz, Steven M.
    Matasar, Matthew J.
    Noy, Ariela
    Palomba, Maria Lia
    Portlock, Carol S.
    Straus, David J.
    Graustein, Tricia
    Zelenetz, Andrew D.
    Moskowitz, Craig H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04) : 456 - 460
  • [8] Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma
    Mendler, J. H.
    Kelly, J.
    Voci, S.
    Marquis, D.
    Rich, L.
    Rossi, R. M.
    Bernstein, S. H.
    Jordan, C. T.
    Liesveld, J.
    Fisher, R. I.
    Friedberg, J. W.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (10) : 1759 - 1764
  • [9] Gemcitabine, vinorelbine and dexamethasone: A safe and effective regimen for treatment of relapsed/refractory hodgkin's lymphoma
    Ganesan, Prasanth
    Mehra, Nikita
    Joel, Anjana
    Radhakrishnan, Venkatraman
    Dhanushkodi, Manikandan
    Kalayarasi, Jayachandran Perumal
    Kannan, Krishnarathinam
    Ganesan, Trivadi S.
    Sagar, Tenali Gnana
    [J]. LEUKEMIA RESEARCH, 2019, 84
  • [10] EFFICACY OF GEMCITABINE AS SALVAGE THERAPY FOR RELAPSED/REFRACTORY AGGRESSIVE NON HODGKIN LYMPHOMA PATIENTS
    Zlotnick, M.
    Avigdor, A.
    Ribakovsky, E.
    Nagler, A.
    Kedmi, M.
    [J]. HAEMATOLOGICA, 2016, 101 : 696 - 696
12345